Clin Exp Otorhinolaryngol.  2020 Feb;13(1):6-7. 10.21053/ceo.2019.01907.

Optimal Treatment for the High-Risk Salivary Gland Cancer

• Woo JS

• KMID: 2501290
• DOI: http://doi.org/10.21053/ceo.2019.01907

Reference

1. Schroeder U, Groppe D, Mueller RP, Guntinas-Lichius O. Parotid cancer: impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction. Cancer. 2008; Aug. 113(4):758–64.

2. Mifsud MJ, Tanvetyanon T, Mccaffrey JC, Otto KJ, Padhya TA, Kish J, et al. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck. 2016; Nov. 38(11):1628–33.

3. Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA. Predictors of nodal metastasis in parotid malignancies: a national cancer data base study of 22,653 patients. Otolaryngol Head Neck Surg. 2016; Jan. 154(1):121–30.

4. Haderlein M, Scherl C, Semrau S, Lettmaier S, Uter W, Neukam FW, et al. High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype. Head Neck. 2016; Apr. 38 Suppl 1:E2041–8.

5. Chen MM, Roman SA, Sosa JA, Judson BL. Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients. Head Neck. 2014; Feb. 36(2):158–63.

6. Jeannon JP, Calman F, Gleeson M, McGurk M, Morgan P, O’Connell M, et al. Management of advanced parotid cancer: a systematic review. Eur J Surg Oncol. 2009; Sep. 35(9):908–15.

7. Franchi A, Gallo O. Distant metastases and management. In : Bradley PJ, Guntinas-Lichius O, editors. Salivary gland disorders and diseases: diagnosis and management. Stuttgart: Thieme;2011. p. 341–9.

8. Kim YH, Chung WK, Jeong JU, Cho IJ, Yoon MS, Song JY, et al. Evaluation of prognostic factors for the parotid cancer treated with surgery and postoperative radiotherapy. Clin Exp Otorhinolaryngol. 2020; Feb. 13(1):69–76.

9. Jegadeesh N, Liu Y, Prabhu RS, Magliocca KR, Marcus DM, Higgins KA, et al. Outcomes and prognostic factors in modern era management of major salivary gland cancer. Oral Oncol. 2015; Aug. 51(8):770–7.

10. Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, et al. Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the national cancer data base. JAMA Otolaryngol Head Neck Surg. 2016; Nov. 142(11):1100–10.